  | Hull, D. (2019). Droits européen et américain de la concurrence : hipsters contre bobo ? Revue de la Faculté de Droit de l'Université de Liège.  Peer reviewed |
 | Hull, D. (04 December 2018). Biologics & Biosimilars [Paper presentation]. Competition Law Challenges. |
 | Hull, D. (14 November 2018). Competition Law Strategies: - Protect Your Brand - - Protect Your Retail Partners - - Protect Your Revenue - [Paper presentation]. Luxury Law New York Summit. |
 | Hull, D. (12 September 2018). Excessive Pricing in the Pharmaceutical Sector: Recent European Cases [Paper presentation]. European Pharma Law Academy. |
 | Hull, D., & Clancy, M. J. (2018). The Application of EU Competition Law in the Pharmaceutical Sector. Journal of European Competition Law and Practice, 389-402. doi:10.1093/jeclap/lpy035 Peer Reviewed verified by ORBi |
 | Hull, D. (2018). Coty, Asics and Google Shopping: Practical Implications for Distribution Strategy. |
 | Hull, D., & Gordley, C. (2018). Gun Jumping in Europe: An Overview of EU and National Case Law. e-Competitions. Peer reviewed |
 | Hull, D. (05 December 2017). Excessive Pricing in the Pharmaceuticals Sector [Paper presentation]. Competition Law in the Pharma Sector 2017. |
 | Hull, D. (2017). The Intel Judgment: Practical Implications for Pricing Strategies. |
 | Hull, D. (13 September 2017). European Competition Law: Recent Developments in the Pharma Sector [Paper presentation]. European Pharma Law Academy. |
 | Hull, D. (16 May 2017). Abuse of Dominance in the Pharmaceuticals Sector: Excessive Pricing, Rebates and Discounts [Paper presentation]. EU Pharmaceutical Law Forum 2017 Brussels. |
 | Hull, D. (February 2017). Application of EU Competition Law in the Pharmaceutical Sector. Journal of European Competition Law and Practice, 3, 205-2018. doi:10.1093/jeclap/lpx004 Peer Reviewed verified by ORBi |
 | Hull, D. (06 December 2016). Patent Settlements under EU Competition Law [Paper presentation]. Competition Law in the Pharma Sector. |
 | Hull, D. (24 May 2016). Abuse of Dominance in the Pharmaceuticals Sector [Paper presentation]. Informa’s 25th Annual EU Pharmaceutical Forum. |
 | Hull, D. (2016). Lundbeck BSC Morning Briefing. |
 | Hull, D. (2016). Patent settlements - The Knowledge Group. |
 | Hull, D., & Clancy, M. J. (2016). Application of EU Competition Law in the Pharmaceutical Sector. Journal of European Competition Law and Practice, 7, 153-161. doi:10.1093/jeclap/lpv093 Peer Reviewed verified by ORBi |
 | Hull, D. (19 May 2015). Competition Cases on Product Denigration: What Can You Say About Competing Products? [Paper presentation]. EU Pharmaceutical Law Forum. |
 | Hull, D. (2010). The AstraZeneca Judgment: Implications for IP and Regulatory Strategies. Journal of European Competition Law and Practice. doi:10.1093/jeclap/lpq057 Peer Reviewed verified by ORBi |
 | Hull, D. (2006). Tying - A transatlantic Perspective. In P. Marsden (Ed.), Handbook of Research in Trans-Atlantic Antitrust (pp. 287-318). Edward Elgar. Peer reviewed |